Committed to patient safety, I attach great importance to the communication of the various stakeholders in the life cycle of medicines, to ensure the proper use of health products
Appearances:
World Drug Safety Congress EU 2025 - Day 1 @ 17:45
Safety committees for advanced therapies in rare diseases
CLAIRE COLPIN / Safety committees for advanced therapies in rare diseases
CLAIRE COLPIN, Lead Safety Officer, Genethon
Claire is a pharmacist with 13 years experience in drug safety. She worked first in post-marketing pharmacovigilance for drug products in dermatology and haematology. She joined Genethon 9 years ago as safety officer on gene therapy products in clinical development.
Manon Sanz / Safety committees for advanced therapies in rare diseases
Manon Sanz, Safety Project Officer (Gene and cell therapies), Généthon
Committed to patient safety, I attach great importance to the communication of the various stakeholders in the life cycle of medicines, to ensure the proper use of health products